Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Sell
44
AMED Quote, Financials, Valuation and Earnings
Last price:
$91.50
Seasonality move
:
7.62%
Day range:
$91.13 - $92.46
52-week range:
$82.15 - $98.95
Dividend yield:
0%
P/E ratio:
69.86x
P/S ratio:
1.29x
P/B ratio:
2.65x
Volume:
302.9K
Avg. volume:
321.1K
1-year change:
-0.82%
Market cap:
$3B
Revenue:
$2.3B
EPS (TTM):
$1.31
AMED Analysts' Consensus Rating
The 10 analysts providing 12-month price projections for Amedisys shares anticipate an average target of $96.86, ranging from a low estimate of $73.00 to a high estimate of $101.00. This average target implies a growth of 5.84% compared to the current stock price of $91.51.
Consensus Price Target
$96.86
Highest Price Target
$101.00
Lowest Price Target
$73.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 0 | 0 | 0 |
| Hold | 9 | 10 | 9 |
| Sell | 1 | 1 | 1 |
| Consensus | Hold | Hold | Hold |
AMED Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
